- Report
- November 2020
- 225 Pages
Global
From €13288EUR$14,995USD£11,531GBP
The Peptide Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Peptide hormones are a type of hormone that are composed of amino acids and are secreted by the endocrine glands. They are involved in a variety of physiological processes, including growth, metabolism, reproduction, and stress response. Peptide hormones are used to treat a variety of endocrine and metabolic disorders, such as diabetes, obesity, and hypothyroidism. They are also used to treat certain types of cancer, such as prostate cancer.
Peptide hormones are typically administered via injection or inhalation. They are generally well-tolerated and have few side effects. However, they can be expensive and may require frequent dosing.
Some companies in the Peptide Hormone market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and Pfizer. Show Less Read more